Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has issued an announcement.
Neuroscientific Biopharmaceuticals Ltd announced a proposed issue of securities, including 40 million options exercisable at $0.07 and 100 million fully paid ordinary shares. This move is expected to enhance the company’s financial resources and potentially strengthen its market position, allowing it to further its research and development efforts in the biopharmaceutical field.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is a company in the biopharmaceutical industry, focusing on the development of innovative therapies for neurological conditions. The company is primarily engaged in creating and advancing treatments that address unmet medical needs in the neuroscience sector.
YTD Price Performance: 16.67%
Average Trading Volume: 165,856
Technical Sentiment Signal: Sell
Current Market Cap: A$5.06M
For a thorough assessment of NSB stock, go to TipRanks’ Stock Analysis page.